Neuroscience

High levels of dopamine may lead to increased risk-taking

Boosting levels of the neurotransmitter dopamine can lead to increased risk-taking, according to research published July 8 in the Journal of Neuroscience. Dopamine is involved in reward learning, and previous research has ...

Medications

What you need to know about the fatal drug fentanyl

A surge in news stories about the drug fentanyl has led to increased efforts to educate students about the hazards of the drug when used recreationally. Fentanyl, a fast-acting painkiller and sedative, is typically prescribed ...

Medical research

Using femtosecond lasers to administer drugs

Combining physics and neurobiology to tackle Parkinson's Disease is research "I would never have been able to do outside of OIST," says Professor Keshav Dani. The Okinawa Institute of Science and Technology Graduate University's ...

Medical research

New target explored for psychiatric drug development

(Medical Xpress)—In a surprising discovery, neuroscientists have found that a breakdown product of cholesterol in the brain may be a target for developing new drugs to treat schizophrenia and other mental illnesses.

Attention deficit disorders

MRI technique reveals low brain iron in ADHD patients

Magnetic resonance imaging (MRI) provides a noninvasive way to measure iron levels in the brains of people with attention deficit hyperactivity disorder (ADHD), according to a study being presented today at the annual meeting ...

Neuroscience

Natural compound mitigates effects of methamphetamine abuse

Studies have shown that resveratrol, a natural compound found in colored vegetables, fruits and especially grapes, may minimize the impact of Parkinson's disease, stroke and Alzheimer's disease in those who maintain healthy ...

page 7 from 12